Bringing a drug to market requires an extraordinary investment. In-house counsel at biotech and pharmaceutical companies routinely face the challenge of developing an IP strategy that maximizes an investment’s return. This is especially difficult when the market for approval of a drug is relatively small. This article provides an overview of the regulatory frameworks for orphan drugs in the United States and other developed and emerging markets.
This White Paper is the full version of the March 2013 Asian Briefings article, "Privacy Statutes in Asia-Pacific Jurisdictions." In addition to serving as a primer on privacy statutes in Asia-Pacific jurisdictions, this White Paper also examines the conflict between the US ediscovery laws and the privacy laws and regulations in the Asian-Pacific region, and attempts by the US Court to reconcile such conflicts. It also recommends best practices for navigating the minefield that exists as a result of such conflicts.
This article offers a brief analysis of data privacy laws and regulations in some key Asia-Pacific jurisdictions, including China, Japan, Australia, South Korea, New Zealand, Taiwan, Singapore, Hong Kong, and India.
The Association of Corporate Counsel and Laurence Simons surveyed corporate legal departments to learn more about their teams in Europe, Middle East and Africa (EMEA). The ACC/Laurence Simons 2012 EMEA Legal Department Survey is available to members and non-members.
The author reflects on an ancient Chinese folktale, and how our perception of luck and success shapes our careers.
Frank Fletcher discusses his time spent as a shipping attorney in Tokyo.
This survey is a self-proclaimed 'work in progress' which will continue to be updated by the Pro Bono Institute. It covers 43 jurisdictions in Europe, Asia and the Pacific region, the Americas, Africa, and the Middle East.
Tips on how to make a business trip a bit more positive.
As outsourcing resources becomes standard practice, change in corporate counsel practice is inevitable.